hphe 4450 - section 03

Upload: christopher-cheatham

Post on 14-Apr-2018

229 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 HPHE 4450 - Section 03

    1/38

    Section 03:

    Pre-Exercise Evaluations

    and Risk Factor Assessment

    ACSM Guidelines: Chapter 3 Pre-Exercise Evaluations

    ACSM Manual: Chapter 3 Risk Factor Assessments

    HPHE 4450

    Dr. Cheatham

  • 7/30/2019 HPHE 4450 - Section 03

    2/38

    Purpose

    The extent of medical evaluations necessarybefore exercise testing depends of the

    assessment of risk.

    For many persons, especially those with CAD orother cardiovascular disorders, the exercise test

    and accompanying physical examination are

    critical to the development of safe and effectiveexercise programs.

    Not all persons warrant extensive testing

  • 7/30/2019 HPHE 4450 - Section 03

    3/38

    In the clinical setting, pre-exercise testevaluations usually include:

    Medical history (ACSM Guidelines, Box 3.1, P. 42)

    Physical examination (ACSM Guidelines, Box 3.2, P.43)

    Laboratory tests (ACSM Guidelines, Box 3.3, P. 44)

    (Next slide)

    We will focus on the blood lipid profile laboratory test

    Purpose

  • 7/30/2019 HPHE 4450 - Section 03

    4/38

    Laboratory Tests

  • 7/30/2019 HPHE 4450 - Section 03

    5/38

    Laboratory Tests

  • 7/30/2019 HPHE 4450 - Section 03

    6/38

    Blood Tests

    Fasted (at least 12 hours) blood test results are relevant to

    determining risk of:

    Hypercholesterolemia (cholesterol)

    Prediabetes (glucose)

    Two options

    1) Refer to local laboratory for testing

    2) Purchase instrumentation to perform tests

    Phlebotomythe practice of withdrawing blood from a blood

    vessel into a blood collection tube

    Insertion of needle into vein (larger-volume sample) Requires professional training

    Finger puncture (smaller-volume sample) Sufficient for mini-analyzers

  • 7/30/2019 HPHE 4450 - Section 03

    7/38

    Risk Factor - Lipids and Lipoproteins

    Blood Lipid Profile: Total Cholesterol (TC)

    Low-Density Lipoprotein (LDL) cholesterol Bad cholesterol

    Transports cholesterol and triglycerides from the liver toperipheral tissues

    High-Density Lipoprotein (HDL) cholesterol Good cholesterol

    Can remove cholesterol from within arteries and transport it

    back to the liver for excretion or re-utilization Ratios

    TC/HDL: Desirable < 4.5 males, < 4.0 females

    LDL/HDL: Average Risk 3.6 males, 3.2 females

    Triglycerides

  • 7/30/2019 HPHE 4450 - Section 03

    8/38

    LDL cholesterol is the primary target for cholesterollowering therapy

    LDL cholesterol is a powerful risk factor for CAD and a

    decrease in LDL markedly decreases the incidence of CAD

    HDL cholesterol level is strongly and inversely

    associated with the risk for CAD

    There is growing evidence for a strong association

    between elevated triglyceride levels and CAD risk

    Risk Factor - Lipids and Lipoproteins

  • 7/30/2019 HPHE 4450 - Section 03

    9/38

    Risk Factor - Lipids and Lipoproteins

  • 7/30/2019 HPHE 4450 - Section 03

    10/38

    Risk FactorBlood Glucose

    Standards set by the American Diabetes

    Association

    Prediabetes risk factor = 100125 mg/dL

    Normal values

  • 7/30/2019 HPHE 4450 - Section 03

    11/38

    Risk Factor - Blood Pressure

    Definition:

    Force of blood against walls of the vasculature

    created by contraction of the heart

    Often assessed by indirect auscultation

    Expressed in millimeters of mercury

    Systolic blood pressure (SBP): Maximum pressure during

    contraction (systole)

    Diastolic blood pressure (DBP): Minimum pressure during

    relaxation (diastole)

  • 7/30/2019 HPHE 4450 - Section 03

    12/38

    The relationship between BP and risk for cardiovascular

    events is continuous, consistent, and independent of

    other risk factors.

    For individuals 40 to 70 yrs of age:

    Each increment of 20 mmHg in SBP or 10 mmHg in DBPdoubles the risk of cardiovascular disease

    Lifestyle modification, including physical activity, weight

    reduction, a DASH eating plan, and moderate alcohol

    consumption are the cornerstones of antihypertensivetherapy.

    Most patients who require drug therapy, require two or

    more antihypertensive meds to achieve the goal BP.

    Risk Factor - Blood Pressure

  • 7/30/2019 HPHE 4450 - Section 03

    13/38

    Theory of Blood PressureMeasurement by IndirectAuscultation

    The inflated BP cuff occludes bloodflow, yielding no sound heard in the

    stethoscope placed beyond theocclusion

    Slow release of cuff pressure allowsthe driving pressure of the blood toforce the blood beyond the cuff and

    yields the first sounds (turbulence)heard in the stethoscope (SBP)

    Sounds cease with full opening ofthe artery as pressure continues todecline and turbulence no longerpresent (DBP)

    Risk Factor - Blood Pressure

  • 7/30/2019 HPHE 4450 - Section 03

    14/38

    Korotkoff Sounds Phase 1: SBP

    Initial onset of sound (clear, repetitive tapping)

    Phase 2: Soft tapping, murmuring, or swishing Typically 10 to 15 mm Hg below phase 1

    Phase 3: Crisp, loud tapping High pitch and intensity

    Phase 4: True DBP Muffling of sound

    Soft or blowing sound

    Considered true DBP, especially during exercise

    Phase 5: Clinical DBP Complete disappearance of sound

    Typically within 8 to 10 mm Hg of phase 4

    Should be recorded if it is significantly different from phase 5

    Risk Factor - Blood Pressure

  • 7/30/2019 HPHE 4450 - Section 03

    15/38

    Risk Factor - Blood Pressure

    Resting Measurement Procedures: The patient should be seated with the

    legs uncrossed

    The BP measurement should be done

    in a relaxed, comfortable setting White coat syndrome

    An appropriate BP cuff should be used

    Center the bladder over the brachial

    artery and secure the appropriate BPcuff snugly at the level of the heart

    Locate the brachial artery pulse in theantecubital fossa and place the

    stethoscope bell over the artery

  • 7/30/2019 HPHE 4450 - Section 03

    16/38

    Resting Measurement Procedures (contd): Quickly inflate the BP cuff to:

    20 mm Hg above SBP (if known)

    150 to 180 mmHg

    Up to 30 mmHg above the disappearance of the radial pulse

    Release pressure 2 to 3 mmHg per heartbeat or 2 to 5mmHg per second to the fifth Korotkoff sound

    Deflate the cuff rapidly to zero after DBP is obtained

    Record the SBP and DBP (fourth and fifth Korotkoffsounds if they are significantly different)

    Wait at least 1 full minute and repeat Values should be within 5 mm Hg of each other; if not,

    repeat

    Risk Factor - Blood Pressure

  • 7/30/2019 HPHE 4450 - Section 03

    17/38

    Risk Factor - Blood Pressure

  • 7/30/2019 HPHE 4450 - Section 03

    18/38

    Blood Pressure - Exercise

    Not in your books.

  • 7/30/2019 HPHE 4450 - Section 03

    19/38

    Blood Pressure - Exercise

    Not in your books.

  • 7/30/2019 HPHE 4450 - Section 03

    20/38

    Blood Pressure - Calculations

    Mean arterial pressure (MAP) Represents the average BP in the arterial system

    MAP = DBP + 1/3(SBP DBP)

    Pulse pressure (PP) Related to stroke volume

    PP = SBP - DBP

  • 7/30/2019 HPHE 4450 - Section 03

    21/38

    Heart Rate

    Heart rate can be measured by: Palpation

    Auscultation

    Telemetry (HR monitors/watches) Electrocardiography (ECG, EKG)

  • 7/30/2019 HPHE 4450 - Section 03

    22/38

    Heart Rate - Palpation

    Palpation: 30- or 60-sec counts are more

    accurate for resting HR

    15- or 30-sec counts are morecommon during exercise

    Begin counting the first beat

    felt as zero (e.g., 0, 1, 2, 3, 4. . .)

    Avoid baroreceptor reflex at the

    carotid artery

  • 7/30/2019 HPHE 4450 - Section 03

    23/38

    Heart Rate - Exercise

    Predicted Maximal HR: 220 - age

  • 7/30/2019 HPHE 4450 - Section 03

    24/38

    Risk FactorObesity (BMI)

    An excessive amount of body fat Recently considered a major, primary CAD risk

    factor

    For risk stratification purposes a height/weightcomparison (BMI) and waist circumference are

    considered

  • 7/30/2019 HPHE 4450 - Section 03

    25/38

    Risk FactorObesity (BMI)

    Assessment standardizations (height)

    Performed with a stadiometer

    Remove shoes and hat (if worn)

    Stand erect, feet flat, heels touching

    Heels, mid- and upper body parts are against the wall

    Take and hold a normal breath, look straight

    Horizontal headboard is lowered tothe top of the head

  • 7/30/2019 HPHE 4450 - Section 03

    26/38

    Risk FactorObesity (BMI)

  • 7/30/2019 HPHE 4450 - Section 03

    27/38

    Risk FactorObesity (BMI)

    Weight protocol

    Scale calibration

    Wear minimal clothing

    Void bladder within 1 hour prior to measurement Ideal measurement is in the morning before meal

    consumption

    Variance in the above standards is acceptable withunderstanding of deviance between measured

    weight and standardized body weight

  • 7/30/2019 HPHE 4450 - Section 03

    28/38

    Risk FactorObesity (BMI)

  • 7/30/2019 HPHE 4450 - Section 03

    29/38

    Risk FactorObesity (BMI)

    Body mass index = __Weight in kg__

    (Height in meters)2

    Example: BMI calculation for a 150-lb, 68-in. client:

    150 pounds / 2.205 = 68.0 kg (convert lbs to kg)

    68 inches 2.54 = 172.7 cm (convert in. to cm)

    172.7 cm / 100 = 1.727 m (convert cm to m)

    1.727 m 1.727 m = 2.98 m2 (convert m to m2)

    BMI = 68.0 kg / 2.98 m2

    = 22.8 kg.

    m2

    (divide kg by m2

    )

  • 7/30/2019 HPHE 4450 - Section 03

    30/38

    Risk FactorObesity (Waist Circ.)

    Abdominal obesity is associated with greater risk Measurement protocol:

    Technician stands to the right of the client

    Measurement made on bare skin Measurement made at the end of a normal exhalation

    Measuring tape is held parallel to the floor and flat

    against skin

    Take multiple measurements to determine smallest site

    Mean of two measurements taken at this site is used

  • 7/30/2019 HPHE 4450 - Section 03

    31/38

    Risk FactorObesity (Waist Circ.)

    Incorrect

    Correct

  • 7/30/2019 HPHE 4450 - Section 03

    32/38

    Risk FactorObesity

  • 7/30/2019 HPHE 4450 - Section 03

    33/38

    Risk FactorPhysical Activity

    Most variable component of total daily energyexpenditure

    Public heath guidelines advocate:

    30 minutes of moderate-intensity activity, 5 days/week, or

    20 minutes of vigorous-intensity exercise 3 days/week

    Assessment goal is to identify those not

    meeting threshold: Regularcontinuous for at least 3 months

    Activity below this level constitutes a risk factorinactivity

  • 7/30/2019 HPHE 4450 - Section 03

    34/38

    Risk FactorPhysical Activity

  • 7/30/2019 HPHE 4450 - Section 03

    35/38

    Risk FactorPhysical Activity

  • 7/30/2019 HPHE 4450 - Section 03

    36/38

    Contraindications to Exercise Testing

  • 7/30/2019 HPHE 4450 - Section 03

    37/38

    Contraindications to Exercise Testing

  • 7/30/2019 HPHE 4450 - Section 03

    38/38

    Contraindications to Exercise Testing

    Patients with absolute contraindications should notperform exercise tests until such conditions are

    stabilized or adequately treated.

    Patients with relative contraindications may be tested

    only after careful evaluation of the risk/benefit ratio.

    Contraindications might not apply in certain specific

    clinical situations, such as soon after an acute

    myocardial infarction, a revascularization procedure,or bypass surgery or to determine the need for, or

    benefit of, drug therapy.